5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 4 53-4, 2003, Pages

  Longnus, Sarah L ^a   Wambolt, Richard B ^a   Parsons, Hannah L ^a   Brownsey, Roger W ^b   Allard, Michael F ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adenosine 5 monophosphate activated protein kinase; Glycogen metabolism; Myocardium

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENINE; ADENOSINE PHOSPHATE; GLUCOSE 6 PHOSPHATE; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; PROTEIN KINASE;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HEART MUSCLE; MALE; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037383091     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00319.2002     Document Type: Article

References (52)

1. Allard MF, Henning SL, Wambolt RB, Granleese SR, English DR, and Lopaschuk GD. Glycogen metabolism in the aerobic hypertrophied rat heart. Circulation 96: 676-682, 1997.
2. Allard MF, Longnus SL, Lydell CP, and Wambolt RB. Effect of 5′-AMP-activated protein kinase activation on glycogen metabolism in working rat hearts (Abstract). Can J Cardiol 16: 183F, 2000.
3. Allard MF, Schonekess BO, Henning SL, English DR, and Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol Heart Circ Physiol 267: H742-H750, 1994.
4. Allard MF, Wambolt RB, Longnus SL, Grist M, Lydell CP, Parsons HL, Rodrigues B, Hall JL, Stanley WC, and Bondy GP. Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am J Physiol Endocrinol Metab 279: E487-E493, 2000.
5. Ally A and Park G. Rapid determination of creatine, phosphocreatine, purine bases and nucleotides (ATP, ADP, AMP, GTP, GDP) in heart biopsies by gradient ion-pair reversed-phase liquid chromatography. J Chromatogr 575: 19-27, 1992.
6. Aschenbach WG, Hirshman MF, Fujii N, Sakamoto K, Howlett KF, and Goodyear LJ. Effect of AICAR treatment on glycogen metabolism in skeletal muscle. Diabetes 51: 567-573, 2002.
7. Bergeron R, Russell RR, 3rd Young LH, Ren JM, Marcucci M, Lee A, and Shulman GI. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol Endocrinol Metab 276: E938-E944, 1999.
8. Bergmeyer HU. Methods of enzymatic analysis. In: Metabolites 1: Carbohydrates, edited by Bergmeyer J and Grassl M. Weinheim, Germany: Verlag Chemie, 1984, p. 191-198.
9. Beyer A, Kitzerow A, Crute B, Kemp BE, Witters LA, and Heilmeyer LM. Muscle phosphorylase kinase is not a substrate of AMP-activated protein kinase. Biol Chem 381: 457-461, 2000.
10. Carling D and Hardie DG. The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta 1012: 81-86, 1989.
11. Corton JM, Gillespie JG, Hawley SA, and Hardie DG. 5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
12. Davies SP, Carling D, Munday MR, and Hardie DG. Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets. Eur J Biochem 203: 615-623, 1992.
13. Gamble J and Lopaschuk GD. Insulin inhibition of 5′-adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metab Clin Exp 46: 1270-1274, 1997.
14. Gao G, Widmer J, Stapleton D, Teh T, Cox T, Kemp BE, and Witters LA. Catalytic subunits of the porcine and rat 5′-AMP-activated protein kinase are members of the SNF1 protein kinase family. Biochim Biophys Acta 1266: 73-82, 1995.
15. Goodwin GW, Arteaga JR, and Taegtmeyer H. Glycogen turnover in the isolated working rat heart. J Biol Chem 270: 9234-9240, 1995.
16. Guinovart JJ, Salavert A, Massague J, Ciudad CJ, Salsas E, and Itarte E. Glycogen synthase: a new activity ratio assay expressing a high sensitivity to the phosphorylation state. FEBS Lett 106: 284-288, 1979.
17. Hardie DG and Carling D. The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997.
18. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5′-AMP-activated protein kinase mediation of the muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998.
19. Henin N, Vincent MF, and Van den Berghe G. Stimulation of rat liver AMP-activated protein kinase by AMP. Biochim Biophys Acta 1290: 197-203, 1996.
20. Henning SL, Wambolt RB, Schonekess BO, Lopaschuk GD, and Allard MF. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation 93: 1549-1555, 1996.
21. Howlett RA, Parolin ML, Dyck DJ, Hultman E, Jones NL, Heigenhauser GJ, and Spriet LL. Regulation of skeletal muscle glycogen phosphorylase and PDH at varying exercise power outputs. Am J Physiol Regul Integr Comp Physiol 275: R418-R425, 1998.
22. Hue L, Bontemps F, and Hers H. The effects of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations. Biochem J 152: 105-114, 1975.
23. Hutber CA, Hardie DG, and Winder WW. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am J Physiol Endocrinol Metab 272: E262-E266, 1997.
24. Kaushik VK, Young ME, Dean DJ, Kurowski TG, Saha AK, and Ruderman NB. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab 281: E335-E340, 2001.
25. Kobayashi K and Neely JR. Mechanism of pyruvate dehydrogenase activation by increased cardiac work. J Mol Cell Cardiol 15:369-382, 1983.
26. Kudo N, Barr AJ, Barr RL, Desai S, and Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270: 17513-17520, 1995.
27. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, and Lopaschuk GD. Characterization of 5′'-AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1301: 67-75, 1996.
28. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, and Winder WW. 5′-AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671, 1999.
29. Longnus SL, Wambolt RB, Barr RL, Lopaschuk GD, and Allard MF. Regulation of myocardial fatty acid oxidation by substrate supply. Am J Physiol Heart Circ Physiol 281: H1561-H1567, 2001.
30. Lopaschuk GD, Belke DD, Gamble J, Itoi T, and Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994.
31. Lowy BA and Williams MK. Lesch-Nyhan syndrome: the synthesis of inosine 5′-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways. Pediatr Res 11: 691-694, 1977.
32. Makinde AO, Gamble J, and Lopaschuk GD. Upregulation of 5′-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circ Res 80: 482-489, 1997.
33. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, and Hue L. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10:1247-1255, 2000.
34. Merrill GF, Kurth EJ, Hardie DG, and Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107-E1112, 1997.
35. Neely JR, Whitfield CF, and Morgan HE. Regulation of glycogenolysis in hearts: effects of pressure development, glucose, and FFA. Am J Physiol 219: 1083-1088, 1970.
36. Park SH, Gammon SR, Knippers JD, Paulsen SR, Rubink DS, and Winder WW. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol 92: 2475-2482, 2002.
37. Poulter L, Ang SG, Gibson BW, Williams DH, Holmes CF, Caudwell FB, Pitcher J, and Cohen P. Analysis of the in vivo phosphorylation state of rabbit skeletal glycogen synthase by fast-atom-bombardment mass spectrometry. Eur J Biochem 175: 497-510, 1988.
38. Randle PJ and Tubbs PK. Carbohydrate and fatty acid metabolism. In: Handbook of Physiology. The Cardiovascular System. The Heart. Bethesda, MD: Am. Physiol. Soc., 1979, sect. 2, vol. I, chapt. 23, p. 805-844.
39. Richards JG, Heigenhauser GJ, and Wood CM. Glycogen phosphorylase and pyruvate dehydrogenase transformation in white muscle of trout during high-intensity exercise. Am J Physiol Regul Integr Comp Physiol 282: R828-R836, 2002.
40. Rossetti L, Lee YT, Ruiz J, Aldridge SC, Shamoon H, and Boden G. Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol Endocrinol Metab 265: E761-E769, 1993.
41. Russell RR III, Bergeron R, Shulman GI, and Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277: H643-H649, 1999.
42. Sabina RL, Kernstine KH, Boyd RL, Holmes EW, and Swain JL. Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac skeletal muscle. Effects on purine nucleotide synthesis. J Biol Chem 257: 10178-10783, 1982.
43. Sim AT and Hardie DG. The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett 233: 294-298, 1988.
44. Skurat AV, Wang Y, and Roach PJ. Rabbit skeletal muscle glycogen synthase expressed in COS cells. Identification of regulatory phosphorylation sites. J Biol Chem 269: 25534-25542, 1994.
45. Swain JL, Hines JJ, Sabina RL, and Holmes EW. Accelerated repletion of ATP and GTP pools in postischemic canine myocardium using a precursor of purine de novo synthesis. Circ Res 51: 102-105, 1982.
46. 14C-glucose. Anal Biochem 25: 486-499, 1968.
47. Verhoeven AJ, Woods A, Brennan CH, Hawley SA, Hardie DG, Scott J, Beri RK, and Carling D. The AMP-activated protein kinase gene is highly expressed in rat skeletal muscle. Alternative splicing and tissue distribution of the mRNA. Eur J Biochem 228: 236-243, 1995.
48. Winder WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 91: 1017-1028, 2001.
49. Winder WW and Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol Endocrinol Metab 270: E299-E304, 1996.
50. Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, and Richter EA. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51: 284-292, 2002.
51. Young ME, Radda GK, and Leighton B. Activation of glycogen phosphorylase and glycogenolysis in rat muscle by AICAR-an activator of AMP-activated protein kinase. FEBS Lett 382: 43-47, 1996.
52. Zhang W, DePaoli-Roach AA, and Roach PJ. Mechanisms of multisite phosphorylation and inactivation of glycogen synthase. Arch Biochem Biophys 304: 219-225, 1993.